COVID Vaccines: XBB Strain Easy Call, But Disagreements Abound Between FDA, Advisors On Logistics

 
• By Sarah Karlin-Smith
  
3D illustration of covid xbb variant
FDA looks likely to recommend XBB 1.5 monovalent COVID vaccines for 2023-2024 • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers